Department of Medical Affairs & Pharmacovigilance • Clinical Formulary Monograph
D 92/6 Okhla Phase 1, New Delhi, 110020, India • Medical Helpline: +91 11-47532297 • Email: contact@vrmedhealthcare.com
Vastofer-10
High-Efficacy HMG-CoA Reductase Inhibitor
Vastofer-10
High-Efficacy HMG-CoA Reductase Inhibitor
Rosuvastatin Calcium IP eq. to Rosuvastatin 10mg
Product Clinical Overview
Vastofer-10 contains Rosuvastatin, a potent hydrophilic statin that lowers LDL-cholesterol, total cholesterol and triglycerides while modestly raising HDL-cholesterol. It is used alongside diet for the management of dyslipidaemia and reduction of cardiovascular risk.
More Images
Actual Vastofer-10 packaging, label panels and blister strip.
Key Ingredients & Pharmacological Profiles
Active chemical constituents, standardized strengths, and physiological roles.
Competitive HMG-CoA reductase inhibitor reducing hepatic cholesterol synthesis.
Approved Clinical Indications
Clinical contexts where this formulation is prescribed under medical supervision.
Pharmacological Mechanism of Action
Rosuvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme of cholesterol biosynthesis, up-regulating hepatic LDL receptors and increasing clearance of circulating LDL-cholesterol.
Formulation & Delivery Technology
- High LDL-C reduction at moderate dose
- Long half-life permits once-daily dosing at any time of day
- Hydrophilic statin with hepatoselective uptake
VR Med Healthcare Pvt. Ltd.
Registered Office & Facility:D 92/6 Okhla Phase 1, New Delhi, 110020, India
Quality Certifications:WHO-GMP Compliant & ISO 9001:2015 Certified
Medical Helpline:+91 11-47532297
Corporate Email:contact@vrmedhealthcare.com
Administration & Packaging Details
As directed by the Physician, usually once daily.
10 x 10 Tablets (Blister Strip)
Store protected from light and moisture, at a temperature not exceeding 30°C.
This formulation monograph is published strictly for the professional scientific reference and educational use of Registered Medical Practitioners, Hospitals, and Clinical Laboratories. The technical and pharmacological details presented herein do not constitute medical advice, diagnostic opinion, or therapeutic claims. These products must be prescribed, dispensed, and administered strictly in accordance with local drug regulations and under the supervision of a licensed physician. VR Med Healthcare Pvt. Ltd. does not promote self-medication, off-label usage, or unsolicited consumer health claims.
More in Cardio & Metabolic
VISTA-Q10
Mitochondrial Bio-Energetic & Cardiovascular Nutrient Matrix
Vildatrol-M
DPP-4 Inhibitor & Biguanide Glycaemic Control Combination
Glifoster
Sulfonylurea & Sustained-Release Biguanide Bilayer Tablet
Enhancing Lives With
Quality Healthcare & Integrity.
VR Med Healthcare has been a trusted benchmark in the Indian pharmaceutical sector since 2010. Headquartered in Okhla Phase 1, New Delhi, our dedicated team of over 100 professionals collaborates with leading physicians and distributors across India to make premium medicines accessible and reliable.
“Our goal is to deliver quality of care in a courteous, respectful, and compassionate manner. We hope you will allow us to care for you and strive to be the first and best choice for healthcare professionals and families.”
Kamal Choudhary
Managing Director, VR Med Healthcare
Established
Approved Formulations
Healthcare Specialists
Manufacturing Standard